
Sridevi Sidambaram
About Sridevi Sidambaram
Data last updated:
Sridevi Sidambaram is a Director at Opinion Bunch Research Private Limited (since 2019), Designated Partner at Enhancly Consultancy Llp (since 2026) and Director at Cellulera Pharma Private Limited (since 2022). The companies operate in Business Services and Pharma. The largest current company by reported revenue is Opinion Bunch Research Private Limited at ₹46.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Feb 2019 | 2019 | ₹46.1 Lakh (FY 2024) | Active | |
| Designated Partner | 07 Feb 2026 | 2026 | Active | ||
| Director | 02 Dec 2022 | 2017 | Active |
Board colleagues of Sridevi Sidambaram
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Nataraj | 08362039 | Opinion Bunch Research Private Limited , Enhancly Consultancy Llp | Director |
| Prasanna Shastry Kammaradi Srinivasa Shastry | 07315842 | Cellulera Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sridevi Sidambaram
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sridevi Sidambaram
Sridevi Sidambaram currently holds 3 directorships: Opinion Bunch Research Private Limited (Director, since 14 Feb 2019, revenue ₹46.1 Lakh (FY 2024)); Enhancly Consultancy Llp (Designated Partner, since 07 Feb 2026); Cellulera Pharma Private Limited (Director, since 02 Dec 2022).
Sridevi Sidambaram was first appointed on 14 Feb 2019 as Director at Opinion Bunch Research Private Limited. The most recent appointment on record is 07 Feb 2026 at Enhancly Consultancy Llp.
The current boards of Sridevi Sidambaram's companies include Ashok Nataraj (Opinion Bunch Research Private Limited), Prasanna Shastry Kammaradi Srinivasa Shastry (Cellulera Pharma Private Limited).